September 06, 2025

Get In Touch

Trans Esophageal Echocardiography Increases Dysphagia Risk In Stroke Patients: Study

Germany: Transesophageal echocardiography (TEE) has a detrimental effect on swallowing in acute stroke patients for at least 24 hours, according to a recent study in the European Journal of Neurology.
Dysphagia (difficulty in swallowing) is common among stroke patients and is associated with worse overall outcomes. TEE is used in the diagnostic evaluation of stroke and is known to cause postoperative dysphagia in cardiac surgery. The prevalence of dysphagia is unknown in acute stroke patients undergoing TEE.
The aim of the Transesophageal Echocardiography – Dysphagia Risk in Acute Stroke (TEDRAS) study by S. Hamzic, Justus‐Liebig‐University, Giessen, Germany, and colleagues was to assess the influence of TEE on swallowing among patients who have experienced acute stroke.
Also Read: Case of Achalasia with cockscrew appearance radiologically
The study included a total of 34 patients with acute stroke. 18 were randomized to the intervention group and 15 to the control group.
Swallowing was tested using flexible endoscopic evaluation of swallowing (FEES) at three different time points in the intervention group (24 h before, immediately after and 24 h after TEE) and in the control group (FEES on three consecutive days and TEE earliest after the third FEES). Validated scales were used to assess dysphagia severity for all time points as primary outcome measures.
The key findings of the repeated‐measures between‐group comparisons were significant increases in the intervention group for the following dysphagia measures: (1) secretion severity score and (2) Penetration‐Aspiration Scale score for saliva for the small and large liquid boil.
Also Read: Cerebral protection system reduces stroke risk in patients undergoing TAVR: JACC
"The results indicate a negative influence of TEE on swallowing in acute stroke patients for at least 24 hours," concluded the authors.
"Transesophageal Echocardiography – Dysphagia Risk in Acute Stroke (TEDRAS): a prospective, blind, randomized and controlled clinical trial," is published in the European Journal of Neurology.
https://onlinelibrary.wiley.com/doi/full/10.1111/ene.14516

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!